Structure Therapeutics (GPCR) Change in Account Payables (2022 - 2026)

Structure Therapeutics' Change in Account Payables history runs 5 years deep, the most recent figure standing at -$5.0 million for Q1 2026.

• On a quarterly basis, Change in Account Payables fell 824.05% year-over-year to -$5.0 million in Q1 2026; TTM through Mar 2026 was -$888000.0, a 140.85% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, up 44.09% from the prior year.
• Change in Account Payables rose to -$5.0 million in Q1 2026 per GPCR's latest filing, from -$5.0 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $8.8 million in Q3 2025 and bottomed at -$5.0 million in Q4 2025.
• The 5-year median for Change in Account Payables is $280000.0 (2025), against an average of $258705.9.
• Across the five-year window, Change in Account Payables soared 1227.42% in 2023 and slumped 1083.69% in 2025, its largest moves.
• Year by year, Change in Account Payables stood at -$124000.0 in 2022, then surged by 1227.42% to $1.4 million in 2023, then tumbled by 130.26% to -$423000.0 in 2024, then slumped by 1083.69% to -$5.0 million in 2025, then advanced by 0.8% to -$5.0 million in 2026.
• Per Business Quant, the three latest GPCR Change in Account Payables figures stand at -$5.0 million (Q1 2026), -$5.0 million (Q4 2025), and $8.8 million (Q3 2025).